Navigation Links
New Drug Application for Ibrutinib Submitted to the U.S. FDA
Date:7/10/2013

yments, and the sufficiency of our current assets to meet these requirements, our future results of operations, our expectations for and timing of ongoing or future clinical trials and regulatory approvals for any of our product candidates, and our plans, objectives, expectations and intentions. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "goal", "should", "would", "project", "plan", "predict", "intend", "target" and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to us and are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance, expected liquidity or achievements to differ materially from those projected in, or implied by, these forward-looking statements. Factors that may cause such a difference include, without limitation, our need for substantial additional financing and the availability and terms of any such financing, the safety and/or efficacy results of clinical trials of our product candidates, our failure to obtain regulatory approvals or comply with ongoing governmental regulation, our ability to commercialize, manufacture and achieve market acceptance of any of our product candidates, for which we rely heavily on collaboration with third parties, and our ability to protect and enforce our intellectual property rights and to operate without infringing upon the proprietary rights of third parties. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements and no assurance can be given that the actual results will be consistent with these forward-looking statements. For more information about the risks and uncertainties that may affect o
'/>"/>
SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain
2. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
3. Bio-AMD, Inc.; Patent Application for Cartridge Test Cap
4. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
5. Rubicon Genomics Launches ThruPLEX™ Family of Sample Preparation Products for Next Generation Sequencing Applications
6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
7. CSL Behring Announces FDA Filing of Biologics License Application for 4-Factor PCC for Urgent Reversal of Vitamin K Antagonist Anticoagulant Therapy
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
9. Philips demonstrates innovations in nuclear medicine imaging with a comprehensive portfolio of NM applications for IntelliSpace Portal
10. Clinical Safety Data for ChromaDex®s Patented pTeroPure® (pterostilbene) Released at 6th World Congress on Polyphenols Applications in Paris
11. UltraTape announces Cleanroom Labels for Cryogenic Laboratory applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014  Auxilium Pharmaceuticals, Inc. ... today confirmed that Auxilium has received an unsolicited, non-binding ... ) to acquire all of the outstanding shares of ... share in cash and Endo stock, subject to due ... unsolicited, non-binding proposal that Auxilium received from Endo on ...
(Date:9/16/2014)... 2014 Hologic, Inc. (NASDAQ: ... Europa del Tomcat, un nuovo strumento preanalitico marcato ... completamente automatizzata, progettata per semplificare la fase preanalitica ... di errore legati alla gestione manuale dei campioni. ... Hologic riduce il carico di lavoro legato al ...
(Date:9/16/2014)... 3SBio Inc., ("3SBio") a leading biotechnology ... focusing on researching, developing, manufacturing and marketing biopharmaceutical ... an exclusive license agreement with JenKem Technology Co., ... in Mainland China of PEG-irinotecan, a long-acting polymer-drug ... over-expressed in many solid tumors, including colorectal, ovarian, ...
Breaking Medicine Technology:Auxilium Responds To Unsolicited Proposal From Endo International 2Auxilium Responds To Unsolicited Proposal From Endo International 3Auxilium Responds To Unsolicited Proposal From Endo International 4Auxilium Responds To Unsolicited Proposal From Endo International 5Auxilium Responds To Unsolicited Proposal From Endo International 6Auxilium Responds To Unsolicited Proposal From Endo International 7Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 2Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 23SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 43SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 5
... CarePoint Partners (CarePoint) today announced that it has ... pharmacy services in Austin, Texas and infusion pharmacy ... area. The Austin location complements CarePoint,s Dallas and ... its southeastern footprint with this expansion into the ...
... Hospira, Inc. (NYSE: HSP ), a leading ... the company will present at the Bank of America / ... 2011, in Las Vegas. The presentation is scheduled ... 11, 2011.  It will be available to all interested parties ...
Cached Medicine Technology:CarePoint Partners Expands Texas Presence and Opens Georgia Market With Acquisition of Premier Infusion 2
(Date:9/17/2014)... 2014 Health.Verticalize, a healthcare marketing company ... health insurance options in the 2014 open enrollment period, ... Moving forward Health Network will be using ... has intentionally remained out of the spotlight for the ... single website to its present position with dozens of ...
(Date:9/17/2014)... Presence Technology, a multinational provider of ... 10.0, which incorporates significant enhancements to meet the ... The Contact Center Agents and Supervisors will have ... a better feel for the performance of their ... who requires additional coaching or mentoring to raise ...
(Date:9/16/2014)... Although more and more people are being affected ... the true daily struggle of the disease. But one ... rob a person of their memory, it takes their ... Forget to Tell You ” (published by Xlibris) shares ... loved one who is suffering from Alzheimer’s disease. Her ...
(Date:9/16/2014)... 17, 2014 Top10BestSEOHosting.com has recently ... most recommended companies for the webmasters that want ... rates. , The senior spokesman for Top10BestSEOHosting.com ... Bluehost and HostMonster are the excellent hosting companies ... provide a wide range of advanced features while ...
(Date:9/16/2014)... Dog Food Secrets , a guide compiled by ... in most commercial dog food but presents a better alternative ... Shane Michaels, prompting an investigative review. , “For most ... member as any other human is, which is why it’s ... due to poor diet” reports Michaels. “Most dog owners don’t ...
Breaking Medicine News(10 mins):Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 2Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 3Health News:Presence Technology’s 10.0 Release Drives Contact Center Web Supervisor Effectiveness While Reducing Operation Costs and Delivering Enterprise Grade Scalability 2Health News:Author shares personal journey about her mother’s Alzheimer’s disease 2Health News:Author shares personal journey about her mother’s Alzheimer’s disease 3Health News:Top10BestSEOHosting.com: Arvixe Is One Of The Best SEO Hosting Suppliers 2Health News:Dog Food Secrets: Review Exposes Andrew Lewis’ Guide to Happier, Healthier Dogs with Homemade Dog Food 2
... ... , ... 24, 2010 -- At just over 18 pounds and with a sound level of only ... lighter and quieter than its battery-operated competitors. Powered by a lithium ion battery with 30 ...
... halt, expert says , TUESDAY, March 23 (HealthDay News) ... trials that are stopped early due to encouraging results, ... of 91 truncated trials with 424 comparable full-length trials, ... in particular, smaller studies -- reported exaggerated or misleading ...
... Walking, biking, dancing can all help normal-weight women as they ... An hour a day of moderate-intensity exercise will prevent weight ... a new study. , ",Moderate intensity, means brisk walking, casual ... Lee, lead author of the study, which is published in ...
... , BOSTON , March 23 ... current ESPN analyst Tedy Bruschi ... Trustees of Partners Continuing Care, the non-acute division of ... Partners Home Care, Partners Continuing Care offers the full ...
... America today hailed the "Patient Protection and Affordable Care Act" signed by the President today. The legislation will greatly expand access to mental health care ... ... , , ... ...
... , March 23 The Alzheimer,s Foundation of America issued the following statement on the health reform legislation that was signed into law today by President Obama:   , ... , ... ... ...
Cached Medicine News:Health News:Advance Introduces the Adgility™ XPB Battery Backpack Vacuum – the Lightest in the Industry, 2Health News:Abbreviated Trials Yield Misleading Results: Study 2Health News:Being Active an Hour a Day Puts Brakes on Weight Gain 2Health News:Being Active an Hour a Day Puts Brakes on Weight Gain 3Health News:Tedy Bruschi Joins the Board of Trustees for Partners Continuing Care and Spaulding Rehabilitation Network 2Health News:Tedy Bruschi Joins the Board of Trustees for Partners Continuing Care and Spaulding Rehabilitation Network 3Health News:Mental Health America Hails Enactment of Historic Health Care Reform Bill 2Health News:Mental Health America Hails Enactment of Historic Health Care Reform Bill 3Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 2Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 3Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: